Carregant...
IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells
CD30 is a novel therapeutic target in human mast cell (MC) neoplasms. In this ‘comparative oncology’ study, we examined CD30 expression and regulation in neoplastic canine MC using a panel of immunomodulatory cytokines [interleukin-2 (IL-2), IL-4, IL-5, IL-6, IL-13 and stem cell factor (SCF)] and th...
Guardat en:
| Publicat a: | Vet Comp Oncol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798577/ https://ncbi.nlm.nih.gov/pubmed/27507155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12260 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|